191 related articles for article (PubMed ID: 30737205)
41. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
42. Influence of Circulating Tumour Cells on Production of IL-1α, IL-1β and IL-12 in Sera of Patients with Primary Diagnosis of Breast Cancer Before Treatment.
Vilsmaier T; Rack B; König A; Friese K; Janni W; Jeschke U; Weissenbacher T;
Anticancer Res; 2016 Oct; 36(10):5227-5236. PubMed ID: 27798883
[TBL] [Abstract][Full Text] [Related]
43. Characterization of circulating tumor cells in breast cancer patients by spiral microfluidics.
Yin J; Wang Z; Li G; Lin F; Shao K; Cao B; Hou Y
Cell Biol Toxicol; 2019 Feb; 35(1):59-66. PubMed ID: 30430365
[TBL] [Abstract][Full Text] [Related]
44. Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.
de Kruijff IE; Sieuwerts AM; Onstenk W; Jager A; Hamberg P; de Jongh FE; Smid M; Kraan J; Timmermans MA; Martens JWM; Sleijfer S
Int J Cancer; 2019 Aug; 145(4):1083-1089. PubMed ID: 30761532
[TBL] [Abstract][Full Text] [Related]
45. A cell transportation solution that preserves live circulating tumor cells in patient blood samples.
Stefansson S; Adams DL; Ershler WB; Le H; Ho DH
BMC Cancer; 2016 May; 16():300. PubMed ID: 27150191
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
47. A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model.
Tu SH; Hsieh YC; Huang LC; Lin CY; Hsu KW; Hsieh WS; Chi WM; Lee CH
BMC Cancer; 2017 Jun; 17(1):440. PubMed ID: 28645267
[TBL] [Abstract][Full Text] [Related]
48. Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial.
Riethdorf S; Müller V; Loibl S; Nekljudova V; Weber K; Huober J; Fehm T; Schrader I; Hilfrich J; Holms F; Tesch H; Schem C; von Minckwitz G; Untch M; Pantel K
Clin Cancer Res; 2017 Sep; 23(18):5384-5393. PubMed ID: 28679772
[No Abstract] [Full Text] [Related]
49. Precisely Enumerating Circulating Tumor Cells Utilizing a Multi-Functional Microfluidic Chip and Unique Image Interpretation Algorithm.
Zhou M; Zheng H; Wang Z; Li R; Liu X; Zhang W; Wang Z; Li H; Wei Z; Hu Z
Theranostics; 2017; 7(19):4710-4721. PubMed ID: 29187898
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
Aktas B; Kasimir-Bauer S; Müller V; Janni W; Fehm T; Wallwiener D; Pantel K; Tewes M;
BMC Cancer; 2016 Jul; 16():522. PubMed ID: 27456970
[TBL] [Abstract][Full Text] [Related]
51. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
[TBL] [Abstract][Full Text] [Related]
52. ClearCell® FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells.
Lee Y; Guan G; Bhagat AA
Cytometry A; 2018 Dec; 93(12):1251-1254. PubMed ID: 30080307
[TBL] [Abstract][Full Text] [Related]
53. Size-based separation methods of circulating tumor cells.
Hao SJ; Wan Y; Xia YQ; Zou X; Zheng SY
Adv Drug Deliv Rev; 2018 Feb; 125():3-20. PubMed ID: 29326054
[TBL] [Abstract][Full Text] [Related]
54. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
55. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
56. Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment.
Smith KJ; Jana JA; Kaehr A; Purcell E; Opdycke T; Paoletti C; Cooling L; Thamm DH; Hayes DF; Nagrath S
Lab Chip; 2021 Sep; 21(18):3559-3572. PubMed ID: 34320046
[TBL] [Abstract][Full Text] [Related]
57. Cryopreservation of Circulating Tumor Cells for Enumeration and Characterization.
Nejlund S; Smith J; Kraan J; Stender H; Van MN; Langkjer ST; Nielsen MT; Sölétormos G; Hillig T
Biopreserv Biobank; 2016 Aug; 14(4):330-7. PubMed ID: 27092845
[TBL] [Abstract][Full Text] [Related]
58. Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology.
Che J; Yu V; Dhar M; Renier C; Matsumoto M; Heirich K; Garon EB; Goldman J; Rao J; Sledge GW; Pegram MD; Sheth S; Jeffrey SS; Kulkarni RP; Sollier E; Di Carlo D
Oncotarget; 2016 Mar; 7(11):12748-60. PubMed ID: 26863573
[TBL] [Abstract][Full Text] [Related]
59. Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients.
Banys-Paluchowski M; Witzel I; Riethdorf S; Rack B; Janni W; Fasching PA; Solomayer EF; Aktas B; Kasimir-Bauer S; Pantel K; Fehm T; Müller V
Anticancer Res; 2017 Jun; 37(6):3117-3128. PubMed ID: 28551653
[TBL] [Abstract][Full Text] [Related]
60. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
Bobek V; Gurlich R; Eliasova P; Kolostova K
World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
